These differential affinities of KRAS mutants for SOS1 might have important implications in tumours, as KRAS binds to SOS1 in the enzymatic pocket but can also regulate its function by binding to an allosteric regulatory pocket [50]. The gene discussed is KRAS; the disease is neoplasm.